Inventor · disambiguated record
Matthew Siegel
Also filed as: SIEGEL MATTHEW · SIEGEL MATTHEW J · SIEGEL MATTHEW JOHN
19 granted patents·9 pending applications·143 citations·filing 2005–2024
93Inventor score
Files withANWITA BIOSCIENCES INC8ARDELYX INC7ALVINE PHARMACEUTICALS INC4UNIV LELAND STANFORD JUNIOR4KHOSLA CHAITAN2
Top patents by PatentIndex Score
28 records- 0195US7462688B2Peptides for diagnostic and therapeutic methods for celiac sprueUNIV LELAND STANFORD JUNIOR·Filed 2005·Granted Dec 9, 2008·60 cites·7 claims
- 0293US7579313B2Transglutaminase inhibitors and methods of use thereofUNIV LELAND STANFORD JUNIOR·Filed 2005·Granted Aug 25, 2009·35 cites·7 claims
- 0392US12240879B2Interleukin-22 fusion proteins, and their pharmaceutical compositionsANWITA BIOSCIENCES INC·Filed 2021·Granted Mar 4, 2025·2 cites·25 claims
- 0491US11692020B2Cytokine fusion proteins, and their pharmaceutical compositions and therapeutic applicationsANWITA BIOSCIENCES INC·Filed 2020·Granted Jul 4, 2023·2 cites·34 claims
- 0589US9993531B2Formulation for oral administration of proteinsALVINE PHARMACEUTICALS INC·Filed 2016·Granted Jun 12, 2018·4 cites·7 claims
- 0689US8871718B2Transglutaminase inhibitors and methods of use thereofUNIV LELAND STANFORD JUNIOR·Filed 2012·Granted Oct 28, 2014·11 cites·5 claims
- 0788US8470782B2Transglutaminase inhibitors and methods of use thereofKHOSLA CHAITAN·Filed 2006·Granted Jun 25, 2013·14 cites·2 claims
- 0887US10376481B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2017·Granted Aug 13, 2019·3 cites·32 claims
- 0986US10968246B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2019·Granted Apr 6, 2021·2 cites·27 claims
- 1081US12215130B2Cytokine-albumin binding moiety fusion proteins and uses thereofANWITA BIOSCIENCES INC·Filed 2019·Granted Feb 4, 2025·2 cites·18 claims
- 1180US10392413B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2016·Granted Aug 27, 2019·3 cites·39 claims
- 1278US10434150B2Methods and pharmaceutical compositions for treating celiac disease and gluten intoleranceALVINE PHARMACEUTICALS INC·Filed 2014·Granted Oct 8, 2019·4 cites·4 claims
- 1373US12398188B2Cytokine fusion proteins, and their pharmaceutical compositions and therapeutic applicationsANWITA BIOSCIENCES INC·Filed 2023·Granted Aug 26, 2025·0 cites·29 claims
- 1469US2025388615A9Substituted 4-phenyl pyridine compounds as non-systemic tgr5 agonistsARDELYX INC·Filed 2024·Application pending·0 cites
- 1568US8778338B2Combination enzyme therapy for digestion of dietary glutenGASS JONATHAN DAVID·Filed 2008·Granted Jul 15, 2014·1 cites·18 claims
- 1667US2023313146A1Intestinal epithelial cell culturesARDELYX INC·Filed 2023·Application pending·0 cites
- 1765US12091438B2Anti-mesothelin constructs and uses thereofANWITA BIOSCIENCES INC·Filed 2019·Granted Sep 17, 2024·0 cites·17 claims
- 1865US8980254B2Formulation for oral administration of proteinsSIEGEL MATTHEW JOHN·Filed 2009·Granted Mar 17, 2015·0 cites·8 claims
- 1963US2019374533A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2018·Application pending·0 cites
- 2061US11897930B2Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applicationsANWITA BIOSCIENCES INC·Filed 2021·Granted Feb 13, 2024·0 cites·28 claims
- 2160US2009156490A1Peptides for diagnostic and therapeutic methods for celiac sprueUNIV LELAND STANFORD JUNIOR·Filed 2008·Application pending·0 cites
- 2259US2024174753A1Fusion proteins, pharmaceutical compositions, and therapeutic applicationsANWITA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2357US12479909B2Albumin binding antibodies and use thereofANWITA BIOSCIENCES INC·Filed 2020·Granted Nov 25, 2025·0 cites·30 claims
- 2456US12084472B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2021·Granted Sep 10, 2024·0 cites·54 claims
- 2554US2008299108A1Peptides for Diagnostic and Therapeutic Methods for Celiac SprueKHOSLA CHAITAN·Filed 2006·Application pending·0 cites
- 2653US2015184146A1Formulation for Oral Administration of ProteinsALVINE PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2749US2015197738A1Acid Stable Prolyl Endopeptidases for Degrading GlutenALVINE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2837US2014205587A1Proteases for Degrading GlutenSIEGEL MATTHEW JOHN·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Siegel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →